Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation

Author： Jin Gui-Hua Hirano Toshio Murakami Masaaki

ISSN： 1460-2377

Source： International Immunology, Vol.20, Iss.6, 2008-06, pp. : 783-789

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IL-2 crucial for dendritic-cell activation

By Lang A.

Trends in Immunology, Vol. 22, Iss. 11, 2001-11 ,pp. : 596-597

Elsevier

Access to resources Recommend Favorite

Immunological effects of the anti-IL-2 receptor monoclonal antibody BT 563 in liver allografted patients

By Nashan B. Schwinzer R. Schlitt H. Wonigeit K. Pichlmayr R.

Transplant Immunology, Vol. 3, Iss. 3, 1995-09 ,pp. : 203-211

Elsevier

Access to resources Recommend Favorite

Prevention of islet graft destruction in diabetic mice and rats by temporary Anti-IL-2 receptor therapy: comparison of different strategies

By Kuttler B. Mathieu C. Bulfone-Paus S. Bouillon R. Diamantstein T. Hahn H.-J.

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4140-4142

Elsevier

Access to resources Recommend Favorite

Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation

By Glanemann M. Langrehr J.M. Raakow R. Guckelberger O. Lohmann R. Klupp J. Lobeck H. Schlag H. Keck H. Bechstein W.O. Settmacher U. Neuhaus P.

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2159-2160

Elsevier

Access to resources Recommend Favorite

IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase

By Jackaman Connie Lansley Sally Allan Jane E. Robinson Bruce W. S. Nelson Delia J.

International Immunology, Vol. 24, Iss. 6, 2012-02 ,pp. : 357-368

Oxford University Press

Access to resources Recommend Favorite